THURSDAY, Nov. 6, 2025 (HealthDay News) — Transgender women using estradiol for their transition don’t run an increased risk ...

Biological sex has a strong influence on disease risk: women are more likely to develop autoimmune disorders, while men face higher rates of cardiovascular disease. These patterns arise in part ...

Gender-affirming hormone therapy does more than reshape the body; it shifts the heart’s electrical rhythm, too, helping it align with a person’s gender identity, according to new research into cardiac ...

BOSTON – The negative mental and physical effects of withholding gender affirming hormone therapy (GAHT) from transgender people may outweigh the risk of GAHT-associated venous thromboembolism (VTE), ...

If you've experienced gender dysphoria — the distressing feeling that occurs when your gender identity differs from the one you were assigned at birth — you might have considered hormone-replacement ...

According to the U.S. Census Bureau, about 2.6 million Americans identify as transgender, meaning their gender identity is different from the sex assigned to them at birth. When transgender people ...

The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...

At long last, the Food and Drug Administration will remove a “black box warning” label required on the packaging of most ...

Taking the hormone estradiol can reverse these effects, but it may also increase endometrial and uterine cancer risks.